Association of TRPM Channel Gene Polymorphisms with Systemic Sclerosis

dc.contributor.authorOztuzcu, Serdar
dc.contributor.authorOnat, Ahmet M.
dc.contributor.authorPehlivan, Yavuz
dc.contributor.authorAlibaz-Oner, Fatma
dc.contributor.authorDonmez, Salim
dc.contributor.authorCetin, Gozde Y.
dc.contributor.authorDemiryurek, Abdullah T.
dc.date.accessioned2026-08-12T17:16:48Z
dc.date.issued2015
dc.departmentFırat Üniversitesi
dc.description.abstractBackground/Aim: Systemic sclerosis (SSc) is an inflammatory disease characterized by vascular abnormalities and fibrosis. The aim of the present study was to investigate the possible role of transient receptor potential melastatin (TRPM) channel genes in the susceptibility and phenotype expression of SSc. Materials and Methods: A total of 339 patients with SSc and 302 healthy controls were studied. Genomic DNA was extracted from leukocytes of the peripheral blood, and 25 single nucleotide polymorphisms in the TRPM channel genes were analyzed by the BioMark HD dynamic array system. Results: There were marked increases in the CC genotype (94.7% vs 81.8%, p<0.0001) and C allele frequencies (97.0% vs. 90.1%, p<0.0001) in the TRPM3 rs1328142, and TT genotype (19.0% vs. 7.8%, p=0.0002) in TRPM5 rs34551253 (Ala456Thr) polymorphism in SSc patients when compared to controls. TRPM3 gene rs1328142 polymorphism was also markedly associated with disease phenotype. However, no associations with the other 23 polymorphisms studied were found. Conclusion: This is the first study to examine the involvement of TRPM channel gene variations on the risk of SSc incidence. Our results suggest roles of TRPM3 and TRPM5 gene variants in the susceptibility to or clinical expression of SSc in the Turkish population.
dc.identifier.endpage770
dc.identifier.issn0258-851X
dc.identifier.issn1791-7549
dc.identifier.issue6
dc.identifier.orcid0000-0003-4995-430X
dc.identifier.orcid0000-0003-1483-2580
dc.identifier.orcid0000-0001-6214-1974
dc.identifier.orcid0000-0001-6871-6521
dc.identifier.orcid0000-0002-8574-5567
dc.identifier.pmid26546534
dc.identifier.scopus2-s2.0-84958152831
dc.identifier.scopusqualityQ2
dc.identifier.startpage763
dc.identifier.urihttps://hdl.handle.net/11508/52427
dc.identifier.volume29
dc.identifier.wosWOS:000365993400016
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherInt Inst Anticancer Research
dc.relation.ispartofIn Vivo
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectCation channels
dc.subjecthaplotype
dc.subjectpolymorphism
dc.subjectscleroderma
dc.subjectsystemic sclerosis
dc.subjecttransient receptor potential melastatin
dc.titleAssociation of TRPM Channel Gene Polymorphisms with Systemic Sclerosis
dc.typeArticle

Dosyalar